Alluvi tirzepatide appears to have emerged as a promising therapeutic option for the treatment of metabolic conditions. This preclinical evaluation investigated the efficacy and profile of tirzepatide 40mg in experimental models of insulin resistance. The studies demonstrated that tirzepatide 40mg substantially enhanced glycemic regulation and decr